Press release
Zaire Helmet Launches with Walkie-Talkie, Bluetooth Audio, Blindspot Alerts, and Ride Recording
Crystal Ice, a consumer tech company based near Boston, MA, is launching the Zaire Helmet on August 8, 2025. This smart helmet combines safety and connectivity with built-in walkie-talkie, Bluetooth audio, blindspot monitoring, and more.Boston, MA - August 2025 - Crystal Ice is officially launching the Zaire Helmet, a groundbreaking smart helmet designed for cyclists who value safety, communication, and convenience. The launch is now live on both crowdfunding platforms: Kickstarter and Indiegogo.
Developed to function as a smart co-pilot on every trail, the Zaire Helmet integrates advanced safety technology and modern communication features in a sleek, lightweight design. Ideal for urban commuters, trail riders, and touring cyclists, the helmet addresses common riding challenges from awareness and connectivity to hands-free operation and incident recording.
Engineered for both urban commuters and adventure cyclists, the Zaire Helmet integrates:
Walkie-talkie communication for real-time group coordination
Bluetooth audio with bone conduction speakers for music and calls
Blindspot monitoring using ultrasonic sensors
Integrated HD video recording for ride documentation
GPS ride logging for route tracking and analytics
Handlebar-mounted remote for hands-free control
Built to meet U.S. CPSC and EU EN1078 safety standards, the Zaire Helmet pairs durability with intelligence. A custom 64GB internal storage system eliminates the need for SD cards, while a browser-based interface allows access to videos and ride data without downloading a dedicated app, saving you phone storage. The helmet's onboard system includes a USB-C port for direct file transfer, as well as a built-in Wi-Fi access point for real-time settings and previews.
As part of Crystal Ice's mission to redefine smart riding gear, the Zaire Helmet has been developed with cyclist feedback and tech-forward design principles. From blindspot alerts to group voice chat, every detail has been crafted to enhance safety, convenience, and performance on the road.
The campaign is currently accepting backers on Kickstarter and IndieGogo with limited early bird pricing. Early supporters are encouraged to back the campaign now to access exclusive launch pricing and limited-edition models. With production ready to begin, the Zaire Helmet marks the next chapter in connected cycling gear.
More details, campaign updates, and pre-order information are available at:
🔗 Kickstarter Campaign - https://www.kickstarter.com/projects/1619635126/zaire-helmets-a-smart-co-pilot-on-every-trail
🔗 Indiegogo Preview - https://www.indiegogo.com/project/preview/048818a7
Stay connected, ride smarter.
CRYSTAL ICE
info@crystalicestudio.com
Boston, MA
Crystal Ice is a U.S.-based technology company focused on developing innovative consumer electronics and wearable tech for everyday use. The company's first product line, Zaire, aims to bring smart functionality to helmets and goggles used in cycling, skiing, and other outdoor activities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Zaire Helmet Launches with Walkie-Talkie, Bluetooth Audio, Blindspot Alerts, and Ride Recording here
News-ID: 4137660 • Views: …
More Releases for Zaire
Ebola Vaccine Market 2018-2026: Market Share with Top Players Merck, Janssen Pha …
Ebola virus disease (EVD) causes viral hemorrhagic fever. It is a life threatening disease, which is spread to humans from animals. Direct contact with body fluids of infected person is one of largest causes of spread of this infection. Symptoms of Ebola disease include high fever, vomiting, sore throat, diarrhea, headache and muscular pain, and in few cases, internal or external bleeding. Although, there is no cure for Ebola virus…
Ebola Vaccine Market Detailed Analysis and Forecast 2018-2026 | Merck, Janssen P …
Ebola virus disease (EVD) causes viral hemorrhagic fever. It is a life threatening disease, which is spread to humans from animals. Direct contact with body fluids of infected person is one of largest causes of spread of this infection. Symptoms of Ebola disease include high fever, vomiting, sore throat, diarrhea, headache and muscular pain, and in few cases, internal or external bleeding. Although, there is no cure for Ebola virus…
Ebola Vaccine Market: Health Improvement Aspects, Expert Reviews, Research 2018 …
According to study published in the journal, The Lancet, in December 2016, rVSV-ZEBOV also known as V920 vaccine, which is jointly developed by Newlink Genetics and Merck and Company, was found to be effective in protection against EVD in phase three trial. rVSV-ZEBOV uses strain of Zaire Ebola virus. Merck is planning to file for final marketing approval of its EVD vaccine with the U.S. FDA in 2018. Moreover, it…
Ebola Vaccine Market Analysis By Key Players Merck and Company, Janssen Pharmace …
In January 2018, GeoVax Labs Inc., published results tested in non-hamate primates for its experimental vaccine, GEO-EM01 against EVD. It is based on company’s novel Modified Vaccinia Ankara Virus like Particle (VLP) platform, which produces non-infectious VLPs in body of vaccinated individual. These VLP’S mimics the natural infection, which triggers the body to produce immune response with both antibodies and T cells.
Download PDF Brochure @ www.coherentmarketinsights.com/insight/request-pdf/1365
According to study published in…
Ebola Vaccine Market in Depth Analysis2026 | Top Key Players Merck and Company, …
In January 2018, GeoVax Labs Inc., published results tested in non-hamate primates for its experimental vaccine, GEO-EM01 against EVD. It is based on company’s novel Modified Vaccinia Ankara Virus like Particle (VLP) platform, which produces non-infectious VLPs in body of vaccinated individual. These VLP’S mimics the natural infection, which triggers the body to produce immune response with both antibodies and T cells.
According to study published in the journal, The Lancet,…
Ebola Vaccine Market With The Global Market Scenario, Distinguishing Regions, An …
Ebola virus disease (EVD) causes viral hemorrhagic fever. It is a life threatening disease, which is spread to humans from animals. Direct contact with body fluids of infected person is one of largest causes of spread of this infection. Symptoms of Ebola disease include high fever, vomiting, sore throat, diarrhea, headache and muscular pain, and in few cases, internal or external bleeding. Although, there is no cure for Ebola virus…